← Back to Search

CPAP for Delirium

N/A

Waitlist Available

Led By Andrew Krystal, MD

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up postoperative day 2

Awards & highlights

No Placebo-Only Group

Summary

Patients with a medical condition known as obstructive sleep apnea may be at increased risk of delirium following surgery. This study loans autotitrating CPAP machines to randomly-selected patients who are at high-risk for obstructive sleep apnea with the goal of preventing post-operative delirium.

Eligible Conditions

Delirium
Sleep Apnea
Obstructive Sleep Apnea

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ postoperative day 2

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~postoperative day 2

This trial's timeline: 3 weeks for screening, Varies for treatment, and postoperative day 2 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Delirium

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: CPAPExperimental Treatment1 Intervention

Patients in the CPAP group will be instructed to wear an autotitrating positive airway pressure (APAP) device any time they sleep prior to surgery and on postoperative days 0, 1, and 2.

Group II: Routine CareActive Control1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

CPAP

2013

Completed Phase 3

~5460

Do I qualify?Apply below to find out